UC Berkeley HHMI
HHMI
UC Berkeley Doudna Research Group UC Berkeley
..: UC Berkeley > DRG > People > Katie Berry :.. ..: Contact Us | Links | Private | Search | © :..

Katie Berry

Translation initiation is the process by which the ribosome binds to and positions a messenger RNA at the initiation (AUG) codon, a prerequisite for all protein synthesis. In humans, the small subunit of the ribosome interacts with numerous protein and nucleic acid ligands before joining with the large subunit to initiate peptide bond catalysis. While many of the molecular players have been elucidated over the past forty years, relatively little is known about the kinetics and molecular mechanism of how the ribosome recruits mRNA, scans to and recognizes the start codon. Understanding the details of how factors control access and assembly of ribosomes at the right site on mRNA will illuminate the mechanisms of translation initiation and enhance our understanding of how the efficiency, fidelity, and regulation of protein synthesis are achieved.

Recent work in the lab has been geared toward developing a reconstituted mammalian system consisting of purified human factors with which we can build preinitiation complexes in vitro, introduce mutant or labeled components, and precisely control which factors are present and at what concentrations. Using this system and a combination of fluorescence spectroscopy and other biochemical techniques, I will quantitatively analyze the mechanism and kinetics of this complex assembly process, focusing at first on factors that bind at the mRNA binding cleft of the 40S ribosome.

In addition to the canonical cap-dependent translation, I am also interested in the particular mechanisms of translation initiation of messages with internal ribosome entry sites (IRESs), such as that from the Hepatitis C Virus. I will use fluorescence techniques to screen for small molecule inhibitors of HCV IRES, that will then be used in structural and biochemical studies of the mechanism of this IRES, and potentially lead to new drugs for Hepatitis C, which infects 1 in 40 people worldwide.

Selected Publications

Fraser, C.S., Berry, K.E., Hershey, J.W. and Doudna, J.A. (2007) eIF3j is located in the decoding center of the human 40S ribosomal subunit. Mol. Cell. 26, 811-819. (1.4MB .pdf)

..: Back :..